Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.
Clinical trial NCT06364176 · RECRUITING
Trial details
- NCT number
- NCT06364176
- Sponsor
- University of Kansas Medical Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-03
- Primary completion
- 2027-05-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.